Axel Schörling
Chief Executive Officer at EQL PHARMA AB
Net worth: 1 M $ as of 2024-03-30
Profile
Axel Schörling is currently the President & Chief Executive Officer at EQL Pharma AB since 2022 and the Director at Gasporox AB since 2023.
Previously, he worked as the Director-Business Controlling at Perstorp AB.
Mr. Schörling holds a graduate degree from Chalmers University of Technology and Handelshögskolan i Göteborg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EQL PHARMA AB
0.88% | 2023-03-30 | 257,113 ( 0.88% ) | 1 M $ | 2024-03-30 |
Axel Schörling active positions
| Companies | Position | Start |
|---|---|---|
| EQL PHARMA AB | Chief Executive Officer | 2022-08-16 |
| GASPOROX AB | Director/Board Member | 2022-12-31 |
Former positions of Axel Schörling
| Companies | Position | End |
|---|---|---|
| PERSTORP HOLDING AB (PUBL.) | Corporate Officer/Principal | - |
Training of Axel Schörling
| Chalmers University of Technology | Graduate Degree |
| Handelshögskolan i Göteborg | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GASPOROX AB | Commercial Services |
| EQL PHARMA AB | Health Technology |
| Private companies | 1 |
|---|---|
Perstorp AB
 Perstorp AB Chemicals: SpecialtyProcess Industries Perstorp AB manufactures and supplies specialty chemicals. The company was founded in 1881 and is headquartered in Perstorp, Sweden. | Process Industries |
- Stock Market
- Insiders
- Axel Schörling